SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021610
Filing Date
2022-08-08
Accepted
2022-08-08 16:06:35
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 762975
2 ex10-1.htm EX-10.1 19413
3 ex10-2.htm EX-10.2 19354
4 ex31-1.htm EX-31.1 19586
5 ex31-2.htm EX-31.2 12000
6 ex32-1.htm EX-32.1 7092
7 ex32-2.htm EX-32.2 4679
  Complete submission text file 0001493152-22-021610.txt   3843837

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ltrn-20220630.xsd EX-101.SCH 31023
9 XBRL CALCULATION FILE ltrn-20220630_cal.xml EX-101.CAL 44206
10 XBRL DEFINITION FILE ltrn-20220630_def.xml EX-101.DEF 96511
11 XBRL LABEL FILE ltrn-20220630_lab.xml EX-101.LAB 260174
12 XBRL PRESENTATION FILE ltrn-20220630_pre.xml EX-101.PRE 197162
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 489288
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39318 | Film No.: 221144338
SIC: 2834 Pharmaceutical Preparations